MET Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
MetLife Inc. is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, options data shows a negative sentiment, and the company's recent financial performance highlights declining profitability. While analysts maintain mostly positive ratings, the lack of significant positive catalysts and the bearish short-term trend make this stock a hold rather than a buy.
The technical indicators for MET are bearish. The MACD histogram is negative (-0.203) and contracting, RSI is neutral at 41.662, and moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 76.69, with support at 74.23 and resistance at 79.15.
MetLife issued $1 billion in subordinated debentures at a 5.85% interest rate to enhance its capital structure, which could support future expansion.
Hedge funds are selling the stock significantly, with a 119940.49% increase in selling activity over the last quarter. Additionally, the stock has a high probability of declining in the short term (-13.43% in the next week, -6.79% in the next month).
In Q4 2025, revenue increased by 26.69% YoY to $23.67 billion, but net income dropped by 37.21% YoY to $778 million. EPS also declined by 34.27% YoY to $1.17, reflecting a significant drop in profitability.
Analysts have mixed views. Recent price target adjustments are mostly downward, with targets ranging from $90 to $101. While most analysts maintain positive ratings (Overweight or Buy), concerns about forward earnings, valuation, and macroeconomic headwinds are evident.
